A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
Consent Codes
GRUFocus / Diseases
Squamous Cell Carcinoma of Head and NeckStudy Design
Case SetData Types
Targeted-CaptureSubjects
42